Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K33/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.20220250023COLLOIDAL BREWING SYSTEM
US 11.08.2022
Int.Class B01J 13/00
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
13Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
Appl.No 17665888 Applicant GAILE MATTISON Inventor GAILE MATTISON

A colloidal brewing system has a transparent container assembly with a watertight bottom portion and an open top portion, the container assembly adapted to contain water. A removable lid electronic housing with two replaceable electrically charged silver rod members is disposed on a bottom portion of the lid member, the rod members extending substantially to near the bottom of the container assembly. A magnetic stir assembly substantially centers an interior bottom portion of the container assembly and to rotate, in the water, on a parallel plane to the bottom portion. A receiver and transmitter coil assembly are disposed within a base container assembly, the base container assembly designed to gravitationally support the watertight bottom portion of the transparent container assembly, the receiver coil and transmitter coil assembly inductively coupled to the magnetic stir assembly. The inventive concept has a rechargeable battery, a control panel, power port members, and handle member.

2.20220249368HEAT RESISTANT CHEWABLE ORAL FORM WITH AN AGAR MATRIX AND MANUFACTURING PROCESS THEREOF
US 11.08.2022
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No 17636526 Applicant PROCAPS S.A. Inventor Andrea Ocampo Salgado

The present invention defines a process for forming a chewable oral dosage form, such as a gum having a pleasant flavor and texture. In particular, the invention includes a process of forming an oral dosage form, comprising: a first step of hydrating a gelling agent of agar-agar and locust bean gum; a second step of mixing in components of the agar matrix; a third step of mixing in an active ingredient; a fourth step of cooking the mixture; a fifth step of flavoring; a sixth step of moulding and gelling; and a seventh step of demoulding, degreasing and drying. The oral dosage form according to the invention also comprises an agar-agar matrix combined with gums, such as locust bean gum, and/or sugar; glycerol; inulin; flavoring agents; citric acid; a coating; and water, to complete the composition, which includes active ingredients.

3.20220249643ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
US 11.08.2022
Int.Class A61K 39/015
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
002Protozoa antigens
015Hemosporidia antigens, e.g. Plasmodium antigens
Appl.No 17629673 Applicant Guangzhou Cas Lamvac Biotech Co., Ltd. Inventor Zhu Tao

An anti-neoplastic combined pharmaceutical composition and application thereof. The combined pharmaceutical composition is prepared from plasmodia and chemotherapeutic drugs. The combined pharmaceutical composition combines chemotherapy with Plasmodium immunotherapy, has high biosafety, has stronger antineoplastic activity than single chemotherapy or single Plasmodium immunotherapy, can prolong the lifetime of cancer patients, and provides a new strategy and idea for cancer treatment. Moreover, the dosage of the chemotherapy drugs can be reduced, toxic and side effects caused by the chemotherapy drugs are reduced, and treatment costs of tumor patients are reduced. In addition, the combined pharmaceutical composition can promote release of a tumor antigen, induces a stronger anti-tumor specific immune response, and exerts the continuous synergistic effect of immunotherapy and chemotherapy.

4.20220249619HIGH CONCENTRATION INSULIN FORMULATION
US 11.08.2022
Int.Class A61K 38/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
28Insulins
Appl.No 17626025 Applicant Novo Nordisk A/S Inventor Jeppe Sturis

The invention concerns a soluble insulin preparation comprising NϵB29-hexadecandioyl-γ-Glu-(desB30) human insulin in a concentration from 1800 nmol/ml to 4200 nmol/ml, Zinc ions in a concentration from 4.0 Zn/6Ins to 7.0 Zn/6Ins, Niacinamide in a concentration from 110 mM to 220 mM or treprostinil in a concentration from 0.02 μg/ml to 1 μg/ml, Citrate in a concentration from 6 mM to 40 mM, and pH in the range from 7.0 to 8.0. The invention further comprises a method for using the soluble insulin preparation for reducing the blood glucose level in a mammal and a process for preparing the soluble insulin preparations.

5.20220248740FOOD COMPOSITIONS FOR WEIGHT MANAGEMENT
US 11.08.2022
Int.Class A23L 33/00
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Appl.No 17597526 Applicant SOCIETE DES PRODUITS NESTLE S.A. Inventor TINU MARY SAMUEL

The present invention concerns a food composition comprising at least one of fiber, beta-carotene, folate, magnesium, zinc, vitamin C, and thiamin, for use in assisting in post-partum weight management.

6.20220250148PREPARATION OF HIGHLY STABLE CONCENTRATED DISPERSIONS OF SILVER NANOPARTICLES USING SYNERGISTIC DISPERSING AGENTS
US 11.08.2022
Int.Class B22F 9/24
BPERFORMING OPERATIONS; TRANSPORTING
22CASTING; POWDER METALLURGY
FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
9Making metallic powder or suspensions thereof; Apparatus or devices specially adapted therefor
16using chemical processes
18with reduction of metal compounds
24starting from liquid metal compounds, e.g. solutions
Appl.No 17684192 Applicant NOBEL /NOBLE ELEMENTS/ LLC Inventor Dan GOIA

Methods for preparing highly stable concentrated dispersions of silver nanoparticles and described herein. Contemplated methods comprise combining a selected polysaccharidic dispersant with a selected non-reacting dispersant to yield concentrated silver dispersions with enhanced stability and lowered undesirable residual organics. Contemplated methods further comprise selecting an appropriate source of silver ions to reduce the ionic strength of the reaction medium and final silver dispersions.

7.20220249521USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
US 11.08.2022
Int.Class A61K 31/6615
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
661Phosphorus acids or esters thereof not having P-C bonds, e.g. fosfosal, dichlorvos, malathion
6615Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
Appl.No 17728807 Applicant Sanifit Therapeutics S.A. Inventor Joan PERELLO BESTARD

Use of a derivative containing C—O—P bonds in a controlled release form to treat patients with kidney failure. Moreover, it comprises the use of said derivatives together with other active substances, which particularly may be selected from a list comprising a calcimimetic, vitamin, phosphate binder, thiosulfate, bisphosphonate, pyrophosphate, citrate, diuretic, antihypertensive and anticholesteraemic agent.

8.WO/2022/167797VAPING E-LIQUID COMPOSITION AND USE THEREOF
WO 11.08.2022
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
Appl.No PCT/GB2022/050279 Applicant THIRTY RESPIRATORY LIMITED Inventor WOOD, Christopher Barry
An aqueous e-liquid composition for use in a method of treatment or prevention of a respiratory disease or disorder, the method including operating an e-cigarette or vaping device including an aqueous e-liquid composition and wherein the e-liquid composition comprises one or more nitrite salt.
9.20220249402DIETARY SUPPLEMENT AND MEDICAMENT
US 11.08.2022
Int.Class A61K 31/122
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
12Ketones
122having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
Appl.No 17446117 Applicant NUTRIOMICS LIMITED Inventor Aydin Berenjian

The present invention is directed to a dietary supplement comprising about 120 mcg of a trans form of Menaquinone-7 (MK-7). In some embodiments, the dietary supplement may further comprise a combination of green-lipped mussel powder and eggshell membrane powder. In other embodiments, the dietary supplement may comprise vitamin D3, vitamin C, and Ginger roots extract.

10.20220249543Trona Based Therapeutic Compositions and Use and Manufacture Thereof
US 11.08.2022
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
Appl.No 17667584 Applicant Moxiyo, LLC Inventor Pete Fuller

A method of treating a topical ailments can include identifying an ailment, procuring a therapeutic composition, and administering the therapeutic composition to a subject. More specifically, the ailment can be associated with a topical region of a subject. The therapeutic composition can be sterilized and include a sodium carbonate mineral and a carboxylic acid. The therapeutic composition can be administered to the topical region of the subject.